What is the pipeline for future medications for obesity?

E Melson, U Ashraf, D Papamargaritis… - International Journal of …, 2024 - nature.com
Obesity is a chronic disease associated with increased risk of obesity-related complications
and mortality. Our better understanding of the weight regulation mechanisms and the role of …

Signaling pathways in obesity: mechanisms and therapeutic interventions

X Wen, B Zhang, B Wu, H **ao, Z Li, R Li… - Signal transduction and …, 2022 - nature.com
Obesity is a complex, chronic disease and global public health challenge. Characterized by
excessive fat accumulation in the body, obesity sharply increases the risk of several …

Cachexia: A systemic consequence of progressive, unresolved disease

M Ferrer, TG Anthony, JS Ayres, G Biffi, JC Brown… - Cell, 2023 - cell.com
Cachexia, a systemic wasting condition, is considered a late consequence of diseases,
including cancer, organ failure, or infections, and contributes to significant morbidity and …

GDF15: emerging biology and therapeutic applications for obesity and cardiometabolic disease

D Wang, EA Day, LK Townsend, D Djordjevic… - Nature Reviews …, 2021 - nature.com
Abstract Growth differentiation factor 15 (GDF15) is a member of the TGFβ superfamily
whose expression is increased in response to cellular stress and disease as well as by …

Browning of the white adipose tissue regulation: New insights into nutritional and metabolic relevance in health and diseases

SA Machado, G Pasquarelli-do-Nascimento… - Nutrition & …, 2022 - Springer
Adipose tissues are dynamic tissues that play crucial physiological roles in maintaining
health and homeostasis. Although white adipose tissue and brown adipose tissue are …

Adipokines, hepatokines and myokines: focus on their role and molecular mechanisms in adipose tissue inflammation

Y Ren, H Zhao, C Yin, X Lan, L Wu, X Du… - Frontiers in …, 2022 - frontiersin.org
Chronic low-grade inflammation in adipose tissue (AT) is a hallmark of obesity and
contributes to various metabolic disorders, such as type 2 diabetes and cardiovascular …

Effects of intermittent fasting on health, aging, and disease

R De Cabo, MP Mattson - New England Journal of Medicine, 2019 - Mass Medical Soc
Effects of Intermittent Fasting on Health and Aging Evidence is accumulating that eating in a
6-hour period and fasting for 18 hours can trigger a metabolic switch from glucose-based to …

GDF15 mediates the effects of metformin on body weight and energy balance

AP Coll, M Chen, P Taskar, D Rimmington, S Patel… - Nature, 2020 - nature.com
Metformin, the world's most prescribed anti-diabetic drug, is also effective in preventing type
2 diabetes in people at high risk,. More than 60% of this effect is attributable to the ability of …

[PDF][PDF] The PNPLA3 I148M variant increases ketogenesis and decreases hepatic de novo lipogenesis and mitochondrial function in humans

PK Luukkonen, K Porthan, N Ahlholm, F Rosqvist… - Cell Metabolism, 2023 - cell.com
Summary The PNPLA3 I148M variant is the major genetic risk factor for all stages of fatty
liver disease, but the underlying pathophysiology remains unclear. We studied the effect of …

Growth/differentiation factor-15 (GDF-15): from biomarker to novel targetable immune checkpoint

J Wischhusen, I Melero, WH Fridman - Frontiers in immunology, 2020 - frontiersin.org
Growth/differentiation factor-15 (GDF-15), also named macrophage inhibitory cytokine-1, is a
divergent member of the transforming growth factor β superfamily. While physiological …